Trial Profile
The Relationship Between the Residual Renal Function and Osteoporosis Treatment
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Bisphosphonates; Teriparatide
- Indications Osteoporosis
- Focus Adverse reactions
- 20 Apr 2016 Planned End Date changed from 1 Jan 2016 to 1 Jan 2019.
- 20 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2018.
- 09 Dec 2014 New trial record